SIGNAL PROCESSING FOR RAMAN SPECTRA FOR DISEASE DETECTION
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2016, Vol 8, Issue 6
Abstract
Raman Spectroscopy enables in-depth study into the molecular structure of solid, liquid and gasses from its scattering spectrum. As such, the spectrum could offer a biochemical fingerprint to identify unknown molecules. Surface Enhanced Raman Spectroscopy (SERS) amplifies the weak Raman signal by 10+3 to 10+7 times, revolutionary making the method appealing to the research community. SERS has been proven useful for disease detection from a medium such as a cell, serum, urine, plasma, saliva, tears. The spectra displayed are noisy and complicated by the presence of other molecules, besides the targeted one. Moreover, the difference between the infected and controlled samples is far too minute for detection by the naked human eyes. Hence, signal processing techniques are found crucial to single out fingerprint of the target molecule from biological spectra. Our work here examines signal processing techniques attempted on SERS spectra for disease detection, such as Principal Component Analysis (PCA), Linear Discriminant Analysis (LDA), Artificial Neural Network (ANN), Support Vector Machine (SVM) and Logistic Regression Analysis (LRA). It is found that PCA-LDA is the most popular (45%), ensued by PCA-ANN (33%) and SVM (22%). PCA-SVM yields the highest in accuracy (99.9%), followed by PCA-ANN (98%) and LRA (97%). PCA-LDA and SVM score the highest in both sensitivity-specificity.Keywords: Raman Spectra, Surface Enhanced Raman Spectroscopy (SERS), Neural Network (NN), Support Vector Machine (SVM), Logistic Regression Analysis (LRA), Principal Component Analysis (PCA), Linear Discriminant Analysis (LDA).
Authors and Affiliations
Afaf Rozan Mohd Radzol, Lee Yoot Khuan, Wahidah Mansor, Faizal Mohd Twon Tawi
Keywords
Related Articles
- EP ID EP576300
- DOI -
- Views 63
- Downloads 0
IN SILICO QUANTITATIVE STRUCTURE – PHARMACOKINETIC RELATIONSHIP MODELING ON ACIDIC DRUGS: HALF LIFE
Objective: Drug half-life (t1/2) is one of the key pharmacokinetic parameters for establishment of dosing regimen. Surprisingly, the relationship between the chemical structure and t1/2 is still poorly explored. The aim...
FOOD–DRUG INTERACTION AND THEIR CLINICAL IMPLICATIONS: SELECTED INVESTIGATIONS
Food-drug interactions occur as a result of pharmacokinetic or pharmacodynamics mechanisms. Pharmacokinetic mechanisms include what the body does to a drug while Pharmacodynamics mechanisms involve what drugs do to the b...
DEVELOPMENT OF NEW ANALYTICAL METHOD AND ITS VALIDATION FOR THE DETERMINATION OF SALBUTAMOL SULPHATE IN BULK AND MARKETED FORMULATIONS
Objective: The present study aims to develop a simple, sensitive, specific, and validated colorimetric method for the quantitative estimation of Salbutamol Sulphate in bulk and pharmaceutical dosage form.Method: A simple...
THERAPIES IN CANCER TREATMENT: AN OVERVIEW
Cancer is one of the most frequent and distressing diseases. The mortality caused by cancer and its prevalence has increased during the last 50 years. Cancer is still one of the most destructive disease of human beings d...
BIOAVAILABILITY ENHANCEMENT OF POORLY SOLUBLE RALOXIFENE BY DESIGNING INCLUSION COMPLEX WITH β–CYCLODEXTRIN
Objective: Raloxifene hydrochloride (RLX) is widely used in the treatment of osteoporosis, but due to its extensive first pass metabolism bioavailability of RLX is remaining only 2%. In addition of that being from BCS cl...